Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society.

Moulin, D.; Clark, A.; Gilron, I.; Ware, M.; Peter N Watson, C; Sessle, B.; Coderre, T.; Morley-Forster, P.; Stinson, J.; Boulanger, A.; Peng, P.; Finley, G.; Taenzer, P.; Squire, P.; Dion, D.; Cholkan, A.; Gilani, A.; Gordon, A.; Henry, J.; Jovey, R.; Lynch, M.; Mailis-Gagnon, A.; Panju, A.; Rollman, G.; Velly, A.

doi:10.1155/2007/730785

Public

Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society.

Shared by NobleBlocks on Jan 1, 2007 • 12:00 AM UTC

Authors:

D. Moulin

A. Clark

I. Gilron

Abstract

Neuropathic pain (NeP), generated by disorders of the peripheral and central nervous system, can be particularly severe and disabling. Prevalence estimates indicate that 2% to 3% of the population in the developed world suffer from NeP, which suggests that up to one million Canadians have this disab...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!